
Debating Alzheimer's Drug Efficacy: Separating Effective Treatments from Ineffective Trials
In the News: Analysis of Alzheimer's Drugs Stirs Debate About Their Effectiveness
A recent review of 17 anti-amyloid drug trials by Cochrane claims that anti-amyloid drugs are ineffective in treating Alzheimer's disease. However, the results of 17 different anti-amyloid drug trials cannot be conflated; Two drugs, lecanemab and donanemab, have proven to be effective in treating Alzheimer's disease and should not be deemed ineffective due to the results of unrelated anti-amyloid drug trials. Read our full opinion: https://na2.hubs.ly/H050v9l0
#AlzheimersResearch #DrugEffectiveness #NeuroscienceDebate #MedicalOpinion #HealthStudies
A recent review of 17 anti-amyloid drug trials by Cochrane claims that anti-amyloid drugs are ineffective in treating Alzheimer's disease. However, the results of 17 different anti-amyloid drug trials cannot be conflated; Two drugs, lecanemab and donanemab, have proven to be effective in treating Alzheimer's disease and should not be deemed ineffective due to the results of unrelated anti-amyloid drug trials. Read our full opinion: https://na2.hubs.ly/H050v9l0
#AlzheimersResearch #DrugEffectiveness #NeuroscienceDebate #MedicalOpinion #HealthStudies
Shared byElliot Silva - A month ago
Log in to comment
Loading ..
Related Articles
Historic Breakthrough on the Horizon in Alzheimer’s Research
New Street Medicine Resource Center Launched to Support Healthcare for Unsheltered Communities
Alzheimer's Disease: 1984 Discovery of Amyloid & Modern Research Advances
Submit Your Abstract for the 2nd Annual Alzheimer's Research Day at USC ATRI
Gabriela Moore Wins Academic Poster Competition for Alzheimer's Research
Alzheimer's Research Evolution: From First Diagnosis to Modern Treatments
4
0/100